Vero-IL2: Began Phase II trial

By WIR Staff | Mar 15, 1999 | 8:00 AM GMT

Transgene S.A. (TRGNY; NM:TRANSGENE), Strasbourg, France

Read the full 66 word article

How to gain access

Continue reading with a
two-week free trial.